# Tvardi Therapeutics news releases

- **Website:** https://tvarditherapeutics.com
- **Location:** Houston, TX, United States
- **Releases:** 1
- **First release:** November 19, 2026
- **Most recent:** November 19, 2026
- **Categories:** Nasdaq:TVRD
- **Web page:** https://www.helpareporter.com/news-releases/tvardi-therapeutics
- **RSS:** https://www.helpareporter.com/news-releases/tvardi-therapeutics/rss.xml

## Releases

### [Tvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback](https://www.helpareporter.com/news-releases/tvardi-therapeutics-advances-next-generation-oral-stat3-inhibitor-tti)

November 19, 2026 · Nasdaq:TVRD

New analysis of Phase 1 exposure data supports the potential for sustained STAT3 inhibition at proposed clinical doses, with minimal predicted effect on STAT1 and STAT5 HOUSTON, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc.
